Pelabresib recently met its primary endpoint of spleen volume reduction and demonstrated favorable trends in symptom improvement
Agreed Price of US$43 per share to deliver 48% premium to unaffected price on May 25, 2023
India’s First Integrated Ayush Wellness Centre to come up in Guwahati, foundation stone laid
Transaction delivers KarXT, a first-in-class M1/ M4 muscarinic receptor agonist with differentiated efficacy and safety
India had proposed for setting up the global standards for millets
India is following a holistic and inclusive approach in alignment with the vison of Universal Health Coverage and the resolute commitment to ‘leave no one behind
The composition of ORAAL is protected by a granted patent in India until November 2033
Chinook Therapeutics is a clinical-stage biopharmaceutical company with two high-value, late-stage assets in development for IgA nephropathy (IgAN), a rare, progressive chronic kidney disease
70+ CXOs from leading healthcare institutions across India attended the confluence at Mumbai
Proposed combination enhances Pfizer’s position as a leading company in oncology
Subscribe To Our Newsletter & Stay Updated
